Allurion Technologies Inc. (ALUR) Stock Price & Analysis
Allurion Technologies Inc. (ALUR) — price $0.002 (0.00%), as of the Nov 20, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Allurion Technologies Inc. · ALUR · NYSE
Allurion Technologies Inc. is a healthcare company focused on obesity treatment through its innovative weight loss platform. The Allurion Program, featuring a swallowable intragastric balloon, aims to provide effective solutions for overweight individuals.
Price as of Nov 20, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.002 | |
| Change on the day | 0.00% | |
| 52-week range | $0.0007 – $8.52 | |
| Shares traded on the day | 2 |
Price & events
Other perspectives
Council score for Allurion Technologies (ALUR): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 21, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 22, 2026, except a card that shows its own read date.
What is Allurion Technologies (ALUR), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Allurion Technologies Inc. (ALUR) is listed on NYSE. It employs 40 people and is led by Shantanu K. Gaur. In Q1 FY2026 it reported revenue of $3M and net income of -$6M.
What do the latest results show for Allurion Technologies (ALUR)?
Short answer · as of
The most recent reported quarter, Q1 FY2026, carried revenue of $3M. Against analyst estimates the company has EPS beat 4 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 FY2026 | $3M | -$6M | -$6.90 (diluted) |
| Q4 FY2025 | $4M | -$6M | -$7.35 (diluted) |
| Q3 FY2025 | $3M | -$12M | -$22.95 (diluted) |
| Q2 FY2025 | $3M | -$9M | -$19.20 (diluted) |
What are the financial strengths and risks for Allurion Technologies (ALUR)?
Short answer · as of
The distress and quality screens read Altman Z -36.57 · Piotroski F 3. Trailing ratios: ROE 44.2% · current ratio 0.30.
Data-derived red flags
- Listing risk — at $0.002 the shares sit below the $1.00 minimum bid NYSE requires for continued listing.
- Financial-distress signal — its Altman Z-Score of -36.57 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
What should you watch next at Allurion Technologies (ALUR)?
Short answer · as of
Current published price targets run low $3.00 · high $3.00 · consensus $3.00 · median $3.00 against a quoted price of $0.002 (as of Nov 20, 2026).
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
- Fewer than two score snapshots exist, so no score trend is shown.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $3.00 – $3.00
- Consensus target
- $3.00
- Median target
- $3.00
Consensus record · Captured .
Measured against a quoted price of $0.002 (as of Nov 20, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Jul 21, 2026
- Transactions
- 6
- Identified insiders
- 1
- Purchases
- 0
- Sales
- 0
- Other transactions
- 6
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held ALUR in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported ALUR in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About ALUR
These answers are editorial: 1 of these 1 answer is drawn from the ALUR research dossier (written Jun 14, 2026 by gpt-4o-mini). Figures in this section are not part of the source register.
What does Allurion Technologies Inc. do?
Allurion Technologies Inc. is a healthcare company that focuses on treating obesity through its innovative Allurion Program. This program includes a swallowable intragastric balloon designed for weight loss without the need for invasive surgery, along with AI-powered remote patient monitoring tools and a comprehensive virtual care suite to support patients in their weight loss journey.
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 18 figures on this page — 12 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com